183 related articles for article (PubMed ID: 19448373)
1. Osteoporosis prophylaxis in patients receiving chronic glucocorticoid therapy.
Sadat-Ali M; Alelq AH; Alshafei BA; Al-Turki HA; Abujubara MA
Ann Saudi Med; 2009; 29(3):215-8. PubMed ID: 19448373
[TBL] [Abstract][Full Text] [Related]
2. Glucocorticoid-induced osteoporosis preventive care in rheumatology patients.
Koller G; Katz S; Charrois TL; Ye C
Arch Osteoporos; 2019 Feb; 14(1):16. PubMed ID: 30723883
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D and bisphosphonate therapy in systemic lupus erythematosus patients who receive glucocorticoids: are we offering the best care?
Sapkota S; Baig S; Hess T; O'Connell AM; Menk J; Shyne M; Fazeli P; Ensrud K; Shmagel A
Lupus; 2020 Mar; 29(3):263-272. PubMed ID: 31996109
[TBL] [Abstract][Full Text] [Related]
4. A survey of steroid-related osteoporosis diagnosis, prevention and treatment practices of pediatric rheumatologists in North America.
Soybilgic A; Tesher M; Wagner-Weiner L; Onel KB
Pediatr Rheumatol Online J; 2014; 12():24. PubMed ID: 25053923
[TBL] [Abstract][Full Text] [Related]
5. Effects of quality indicator monitoring for glucocorticoid-induced osteoporosis and trends of drug treatment in a Japanese hospital.
Suda M; Suyama Y; Ohde S; Tsuda T; Sawada H; Kishimoto M; Okada M
Int J Rheum Dis; 2018 May; 21(5):975-981. PubMed ID: 29878618
[TBL] [Abstract][Full Text] [Related]
6. Glucocorticoid-Induced Osteoporosis Prevention in Polymyalgia Rheumatica Patients.
Swami T; Molloy C
Ir Med J; 2020 Mar; 113(3):36. PubMed ID: 32815678
[TBL] [Abstract][Full Text] [Related]
7. Evidence-based guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis: a consensus document of the Belgian Bone Club.
Devogelaer JP; Goemaere S; Boonen S; Body JJ; Kaufman JM; Reginster JY; Rozenberg S; Boutsen Y
Osteoporos Int; 2006 Jan; 17(1):8-19. PubMed ID: 16217586
[TBL] [Abstract][Full Text] [Related]
8. Use of a computerized order set to increase prescription of calcium and vitamin D supplementation in patients receiving glucocorticoids.
Kohler MJ; Amezaga M; Drozd J; Crowley ST; Gulanski B; Anderson DR; Fraenkel L
J Gen Intern Med; 2013 Jun; 28(6):825-9. PubMed ID: 23404201
[TBL] [Abstract][Full Text] [Related]
9. Quality assurance study of the use of preventative therapies in glucocorticoid-induced osteoporosis in early inflammatory arthritis: results from the CATCH cohort.
McKeown E; Bykerk VP; De Leon F; Bonner A; Thorne C; Hitchon CA; Boire G; Haraoui B; Ferland DS; Keystone EC; Pope JE;
Rheumatology (Oxford); 2012 Sep; 51(9):1662-9. PubMed ID: 22539481
[TBL] [Abstract][Full Text] [Related]
10. Calcium, vitamin D and etidronate for the prevention and treatment of corticosteroid-induced osteoporosis in patients with rheumatic diseases.
Loddenkemper K; Grauer A; Burmester GR; Buttgereit F
Clin Exp Rheumatol; 2003; 21(1):19-26. PubMed ID: 12673885
[TBL] [Abstract][Full Text] [Related]
11. Glucocorticoid-induced osteoporosis: 2019 concise clinical review.
Adami G; Saag KG
Osteoporos Int; 2019 Jun; 30(6):1145-1156. PubMed ID: 30805679
[TBL] [Abstract][Full Text] [Related]
12. Calcium and vitamin D in the prevention and treatment of osteoporosis - a clinical update.
Boonen S; Vanderschueren D; Haentjens P; Lips P
J Intern Med; 2006 Jun; 259(6):539-52. PubMed ID: 16704554
[TBL] [Abstract][Full Text] [Related]
13. A double blind placebo controlled study to determine the effects of intermittent cyclical etidronate on bone mineral density in patients on long-term oral corticosteroid treatment.
Pitt P; Li F; Todd P; Webber D; Pack S; Moniz C
Thorax; 1998 May; 53(5):351-6. PubMed ID: 9708225
[TBL] [Abstract][Full Text] [Related]
14. Prevention of glucocorticoid-induced osteoporosis in immunobullous diseases with alendronate: a randomized, double-blind, placebo-controlled study.
Tee SI; Yosipovitch G; Chan YC; Chua SH; Koh ET; Chan YH; Tan SS; Tsou IY; Tan SH
Arch Dermatol; 2012 Mar; 148(3):307-14. PubMed ID: 22105813
[TBL] [Abstract][Full Text] [Related]
15. Prevention, diagnosis, and treatment of glucocorticoid induced osteoporosis by rheumatologists in a Latin-American city.
Caballero-Uribe CV; Acosta-Velez JG; Hernandez-Ruiz EA; Andrade Rodado FM; PeƱuela-Epalza M
J Clin Rheumatol; 2008 Jun; 14(3):153-5. PubMed ID: 18525434
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of long term steroid treatment and the frequency of decision making to prevent steroid induced osteoporosis in daily clinical practice.
Gudbjornsson B; Juliusson UI; Gudjonsson FV
Ann Rheum Dis; 2002 Jan; 61(1):32-6. PubMed ID: 11779755
[TBL] [Abstract][Full Text] [Related]
17. [Therapy of glucocorticoid induced osteoporosis].
Arazzi M; Di Fulvio G; Di Pietro LO; Grabocka X; Longo MO; Micioni G; Pezzutto A; Piscitani L; Schiazza A; Silvestri S; Vigilante G; Amoroso L; Bonomini M
G Ital Nefrol; 2017 Dec; 34(Nov-Dec):. PubMed ID: 29207221
[TBL] [Abstract][Full Text] [Related]
18. Status of Glucocorticoid-Induced Osteoporosis Preventive Care in Korea: A Retrospective Cohort Study on the Korean National Health Insurance Service Database.
Song BW; Kim AR; Kim MA; Kim HS; Lee SG
Medicina (Kaunas); 2022 Feb; 58(2):. PubMed ID: 35208647
[No Abstract] [Full Text] [Related]
19. [Secondary osteoporosis. Glucocorticoid induced osteoporosis in childhood : prophylaxis and treatment].
Tanaka H
Clin Calcium; 2007 Jul; 17(7):1114-9. PubMed ID: 17607080
[TBL] [Abstract][Full Text] [Related]
20. Use of bisphosphonates and dual-energy X-ray absorptiometry scans in the prevention and treatment of glucocorticoid-induced osteoporosis in rheumatology.
Wall E; Walker-Bone K
QJM; 2008 Apr; 101(4):317-23. PubMed ID: 18270228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]